# Prophylactic Permanent Pacemaker in Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Implantation

Study · id `cardio:ct-nct05889208` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05889208](<https://clinicaltrials.gov/study/NCT05889208>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05889208

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems; Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 320 participants.

## Technical summary

Registry record NCT05889208. Randomized; no masking; primary purpose treatment. Start 2023-12-01 (anticipated); primary completion 2026-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 320 participants (planned count; ClinicalTrials.gov record NCT05889208, source copy `cardio:ctgov-nct05889208-2023-06-05`, retrieved 2026-10-26)
- Planned start: 2023-12-01 (anticipated) (ClinicalTrials.gov record NCT05889208, source copy `cardio:ctgov-nct05889208-2023-06-05`, retrieved 2026-10-26)
- Primary completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT05889208, source copy `cardio:ctgov-nct05889208-2023-06-05`, retrieved 2026-10-26)
- Completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT05889208, source copy `cardio:ctgov-nct05889208-2023-06-05`, retrieved 2026-10-26)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "NOT\_YET\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05889208-2023-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Prophylactic Permanent Pacemaker in Patients With Right Bundle Branch Block Undergoing Transcatheter Aortic Valve Implantation
- Acronym: TAVI-PACE
- Condition: Aortic Stenosis
- Condition: Right Bundle-Branch Block
- Intervention (Device): Prophylactic pacemaker implantation
- Lead sponsor: Aalborg University Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Heart block (`cardio:heart-block`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Aalborg University Hospital (`cardio:org-aalborg-university-hospital`)

## Provenance

Content hash: 582329711b2f3be7b0ae7dd10a9fb563b67cd539a17724b5dda466458be73f8f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
